Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00800722 · ClinicalTrials.gov registry record · Phase 1
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
A Phase 1 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00800722 is a Phase 1 study that has completed, run by University of California, Irvine. The registered enrollment target is 21 participants.
The verdict
NCT00800722, a Phase 1 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researchers want to determine whether the combined use of pulsed dye laser therapy and rapamycin will improve PWS therapeutic outcome.
Interventions
- DRUG Rapamycin Treatment of Port Wine Stain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00800722
The ClinicalTrials.gov registry entry for NCT00800722 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rapamycin Treatment of Port Wine Stain is the first listed.
NCT00800722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00800722 about?
NCT00800722 is a clinical study titled "A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.". The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researchers want to determine whether the combined use of pulsed dye laser therapy and rapamycin will improve PWS therapeutic outcome.
What is the current status of trial NCT00800722?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2008-11. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00800722?
The interventions under investigation include: Rapamycin Treatment of Port Wine Stain (DRUG).
Who is sponsoring clinical trial NCT00800722?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.